Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis
IntroductionMultiple sclerosis (MS) is a potentially disabling disease that damages the brain and spinal cord, inducing paralysis of the body. While MS has been known as a T-cell mediated disease, recent attention has been drawn to the involvement of B cells in its pathogenesis. Autoantibodies from...
Автори: | Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, Yoe-Sik Bae |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Frontiers Media S.A.
2023-06-01
|
Серія: | Frontiers in Immunology |
Предмети: | |
Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151511/full |
Схожі ресурси
Схожі ресурси
-
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
за авторством: Michael Basler, та інші
Опубліковано: (2014-01-01) -
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
за авторством: Leonie Stolz, та інші
Опубліковано: (2017-07-01) -
Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior
за авторством: Pece Kocovski, та інші
Опубліковано: (2021-06-01) -
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
за авторством: Kaili Lu, та інші
Опубліковано: (2020-02-01) -
Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects
за авторством: Jeong Hyo-Soon, та інші
Опубліковано: (2011-08-01)